Diabetes trial gets off to promising start

It was only the first day of a screening trial, but a Queensland pharmacy has already discovered a customer at risk of developing type 2 diabetes.

The Ashmore Plaza Amcal Chempro Chemist is one of 363 sites involved in the Pharmacy Diabetes Screening Trial.

Pharmacists will recruit up to 60 volunteers by approaching customers in the target age group (35 to 74 years) on the pharmacy floor and inviting them to make an appointment.

First patients will be screened using the Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK).

Those deemed at risk will then take the Hba1C test.

Anyone with a high score will be referred to a GP.

This model is one of three being tested in the $50 million trial which is funded by the 6CPA.

One of the first people to be screened at the pharmacy this week was Health Minister Sussan Ley.

While she got the all-clear, another patient